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Abstract
Background: Thyrotroph embryonic factor (TEF), a member of the PAR bZIP family of transcriptional regulators, has been
involved in neurotransmitter homeostasis, amino acid metabolism, and regulation of apoptotic proteins. In spite of its
relevance, nothing is known about the regulation of TEF.
Principal Findings: p53-dependent genotoxic agents have been shown to be much more harmful for PAR bZIP-deficient
mice as compared to wild type animals. Here we demonstrate that TEF expression is controlled by p53 through
upregulation of microRNA-125b, as determined by both regulating the activity of p53 and transfecting cells with microRNA-
125b precursors. We also describe a novel role for TEF in controlling actin distribution and cell shape in mouse fibroblasts.
Lack of TEF is accompanied by dramatic increase of cell area and decrease of elongation (bipolarity) and dispersion
(multipolarity). Staining of actin cytoskeleton also showed that TEF (2/2) cells are characterized by appearance of
circumferential actin bundles and disappearance of straight fibers. Interestingly, transfection of TEF (2/2) fibroblasts with
TEF induced a wild type-like phenotype. Consistent with our previous findings, transfection of wild type fibroblasts with
miR-125b promoted a TEF (2/2)-like phenotype, and a similar but weaker effect was observed following exogenous
expression of p53.
Conclusions/Significance: These findings provide the first evidence of TEF regulation, through a miR-125b-mediated
pathway, and describes a novel role of TEF in the maintenance of cell shape in fibroblasts.
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Introduction
Mammalian homologs of the C. elegans protein CES-2 include
thyrotroph embryonic factor (TEF), albumin D-site-binding protein
(DBP), and hepatic leukemia factor (HLF) [1,2,3] which are members
of the proline- and acid-rich (PAR) subfamily of basic region leucine-
zipper (bZIP) transcription factors. Mice deficient for all three PAR
bZIP proteins are highly susceptible to generalized spontaneous and
audiogenic epilepsies that frequently are lethal [4]. These proteins have
recently been described to control the expression of many enzymes and
regulators involved in detoxification and drug metabolism [5].
Additionally, we have shown that TEF regulates the expression of
two genes, bcl-gS and bik, involved in the execution of apoptosis [6,7].
Genotoxic agents such as cyclophosphamide and mitoxantrone, which
induce p53-dependent apoptosis, have been shown to be much more
harmful for PAR bZIP-deficient mice as compared to wild type
animals [5]. However, no relationship between p53 and PAR bZIP
transcription factors has been established to date.
An interesting but not well known activity of p53 is its capacity
to modify cell shape. Expression of some p53 mutants and to a
lesser extent wild type p53, lead to increase of average cell area,
decrease of dispersion and elongation indices, and re-appearance
of actin bundles in both Ras-transformed fibroblasts and
epitheliocytes [8]. The key factors that are responsible for the
shape of a cell are primarily the cytoskeletal structures, including
microfilaments, microtubules and intermediate filaments [9,10]. A
set of intracellular molecules are likely to act in a spatially
determining way to organize these shape-determining factors on a
particular path. However, we know little about these signalling
networks, although recent data have identified a large number of
genes that influence cytoskeletal organization and morphology in
Drosophila cell lines [11,12], which indicates the complexity of the
problem. Although stress fibers (bundles of actin filaments) play a
central role in adhesion, motility, and morphogenesis of eukaryotic
cells, the mechanism of how these and other contractile
actomyosin structures are controlled and redistributed in the cell
is not well understood. Additionally, several groups have
established the relationship between p53 and microRNAs. These
studies highlight the microRNAs miR-34a and miR-34b/c as
direct, conserved p53 target genes that presumably mediate many
PLoS ONE | www.plosone.org 1 February 2011 | Volume 6 | Issue 2 | e17169of the activities of p53 in response to stress stimuli [13].
Responding to stresses, cells either choose to restore or reprogram
their gene expression patterns, which is partly mediated by
microRNA functions. In turn, these changes determine the
specificity, timing, and concentration of gene products expressed
upon stresses [14]. Recent evidence indicate that p53 is able to
induce the expression of a number of microRNAs by either direct
transcriptional activation or regulation of the microRNA process-
ing complex. Direct targets of p53 include the already mentioned
miR-34 and also miR-192, miR-194 and miR215, which then
modulate MDM2 expression [15]. The proposed microRNAs that
are regulated through the processing machinary include let-7,
miR-200c, miR-143, miR-107, miR-16, miR-145, miR-134, miR-
449a, miR-503, and miR-21 [16]. In the present study, we
demonstrate that TEF is downregulated by miR-125b through
activation of p53, and that this novel regulation pathway
contributes to determine the actin distribution and the shape of
fibroblasts.
Results
p53 regulates the expression of TEF
Genotoxic agents that induce p53-mediated apoptosis, are more
harmful for PAR bZIP-deficient mice as compared to wild type
animals [5]. TEF and other PAR bZIP proteins stimulate the
transcription of genes encoding enzymes and regulators important
for the defense against xenobiotics, thus, contributing to cell
survival. We and others have described that TEF seems to be the
major PAR bZIP member responsible for the expression of
different target genes [4,7]. Thus, we wanted to study whether
there was a relationship between both transcription factors, p53
and TEF. We first explored whether p53 was able to control the
expression of TEF. For this purpose, we used NB4 cells expressing
a temperature-sensitive p53 mutant, and NTERA2 cells trans-
fected with a p53-specific shRNA. Both cell systems were
demonstrated to behave as expected. NB4 cell line upregulated
p53 when shifted to 32uC as determined by the increase of p21
protein levels (Figure 1A), which correlated with an increase of
more than 60% of apoptotic cells assessed by loss of mitochondrial
membrane potential (Figure 1B). On the other hand, NTERA2
cells showed a downregulated expression of p53 when transfected
with the specific shRNA, which was even more evident when this
cell line was treated with cisplatin (Figure 1C). As expected,
downregulation of p53 dramatically reduced the apoptotic
response to the chemotherapeutic drug (data not shown). Both
cell systems were used to study the contribution of p53 to the
transcriptional activity of TEF. Interestingly, the DNA binding
capacity of TEF was reduced in NB4 at 32uC and increased in p53
knockdown NTERA2 cells (Figure 2A). Moreover, shift to 32uC
promoted a clear downregulation of the TEF protein levels
(Figure 2B). In view of these data, we tested whether p53 was able
to modulate the transcription of TEF. HEK293T cells were
transfected with a construct containing the luciferase gene driven
by the TEF promoter. As shown in Figure 2C, overexpression of
p53 did not modify the activity of this promoter although it
efficiently induced the mdm2 promoter, a known target of p53.
miR-125b mediates TEF silencing
Increasing evidence has suggested that miRs are translational
repressor components of multiple signalling pathways. It is now
known that p53 induces the expression of miRs such as the miR-
34 family [17]. Therefore, we searched for miR target sequences
in the TEF gene using the TargetScan and PicTar prediction
programs [18,19], and identified a highly conserved seed sequence
for miR-125a and miR-125b homologs within the 39-untranslated
region of TEF that exhibit an almost perfect complementarity with
both miRs (the interaction between miR-125b and human TEF is
shown in Figure 3A). The maximum free energies predicted for
the configuration between the target element in TEF and the seed
sequences in miR-125 are –25.7 kcal/mol (miR-125a) and –
27.4 kcal/mol (miR-125b) as determined by mFold analysis and
consistent with authentic miR targeting [20].
By using quantitative PCR, we then showed that activation of
p53 in NB4 cells increased the expression of miR-125b to nearly
the same extend as did the p53 target miR-34a, but had no effect
on the levels of miR-147, used here as a p53-independent miR
(Figure 3B). The role of p53 in promoting the expression of miR-
125b was further confirmed by transfection of NB4 cells with a
p53-containing vector. Both miR-34a and miR-125b were
upregulated, whereas the levels of miR-147 remained unmodified
(Figure 3C). In order to verify whether the binding site for miR-
125b identified in the TEF gene can repress translation, we
introduced this conserved sequence downstream of the luciferase
gene in a reporter construct. Transfection of NB4 cells that express
Figure 1. Cell models genetically modified to study p53-
dependent signalling pathways. (A) NB4 cells transfected with a
temperature-sensitive mutant form of p53 were incubated at the
indicated conditions and the activity of p53 was determined by
analyzing the protein levels of p21. (B) The proportion of apoptotic NB4
cells in response to p53 activation was determined by the loss of
mitochondrial membrane potential in a flow cytometer. (C) NTERA2
cells were stably transfected with a p53-specific or a control shRNA. The
knockdown efficiency was determined by western blot following
incubation of cells in the presence of 12 mM cisplatin for 24 h. The
expression of a-Tubulin was determined to assure equal loading.
doi:10.1371/journal.pone.0017169.g001
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subsequent p53 activation led to a significant and specific
reduction (about 3-fold) of the luciferase activity (Figure 3D). A
more direct evidence was obtained following contransfection of
HEK293T cells with the same luciferase construct and with miR-
125b. Transfection with the specific microRNA significantly
reduced the levels of luciferase activity. This reduction was not
observed when cells were transfected with miR-147 or when the
reporter vector contained a mismatch sequence (Figure 3E). To
further extend these results we studied whether miR-125b was able
to repress the expression of TEF by transfecting wild type
fibroblasts with miR-125b. The transfection efficiency was in all
experiments around 50%, as determined by flow cytometry using
a FAM-conjugated control miR (Figure 4A). We found that miR-
125b downregulated (2- to 3-fold) the protein levels of TEF
(Figure 4B) which correlates with the lack of interaction between
TEF and its DNA target sequence in cells overexpressing miR-
125b as determined by EMSA (Figure 4C). Similar but less
pronounced effects were observed with miR-125a (data not
shown).
mir-125b-TEF regulation pathway controls fibroblast cell
shape
Wild type and TEF (2/2) fibroblasts exhibit very different
morphologies. Wild type cells display an elongated and stellate
phenotype, whereas knockout cells appear to be larger and
rounded (Figure 5A). The shape changes are generally accepted to
be driven by the actin cytoskeleton, which together with accessory
proteins make up the cell cortex. Consistently, we found that F-
actin filaments were distributed along the periphery of knockout
cells forming circumferential bundles (Figure 5B). When cells are
attached to a planar substratum and moving in low density fluid
cultures, there is little in the way of external forces to resist cell
shape changes. We analyzed F-actin distribution in confluent
cultures with a mechanically denuded area and found the staining
to be localized to protrusions at the leading edge in cultures of wild
type fibroblasts, and evenly distributed in filaments that were
oriented more parallel to the cell edge in TEF(2/2) fibroblasts
(Figure 5C). The dynamic organization of the actin cytoskeleton is
regulated by small GTPases of the Rho family, in particular Rac1,
RhoA and Cdc42 [21]. Since TEF is a transcription factor, we
studied whether the expression of these genes was modified by the
presence of TEF. As shown in Figure 5D, the mRNA levels of
Rac1, RhoA and Cdc42 were very similar in both wild type and
TEF (2/2) fibroblasts. Actin cytoskeleton is reorganized during
mitosis to form rounded cells, and re-established after cell division
allowing cells to regain a more extended shape. Therefore, we
analyzed the cell cycle phase distribution in wild type and TEF
(2/2) fibroblasts (Figure 5E) and found a similar pattern in both
cell populations, suggesting that the difference in cell shape was
not due to differences in cell division rates.
To further confirm that TEF is a relevant factor to control the
distribution of actin filaments in fibroblasts, we transiently
cotransfected TEF (2/2) cells with TEF and EGFP. The
transfection efficiency was about 20% as determined by flow-
cytometric quantification of EGFP-positive cells. Of these, almost
all (more than 80%) restored the actin filament pattern
characteristic of wild type cells (Figure 6A). Moreover, when wild
type fibroblasts were transfected with miR-125b precursor, actin
filaments were redistributed along the cell periphery and
fibroblasts acquired a rounded shape in more than 60% of
transfected cells (Figure 6B) resembling the morphology of TEF
(2/2) fibroblasts. To establish that the effect of miR-125b on the
distribution of actin filaments was mediated through downregu-
lation of TEF, we flow sorted DsRed-positive wild type fibroblasts
cotransfected with a TEF cDNA lacking the mir-125b binding site,
which were subsequently transfected with miR-125b. Consistently,
overexpression of TEF significantly (p,0.01) reduced the number
of TEF(2/2)-like cells as compared with fibroblasts transfected
with either an empty vector or an unmodified TEF cDNA
(Figure 6C). In addition, a similar but less pronounced
morphological pattern was observed in about 50% of cells
transfected with p53 and EGFP (Figure 6D). These data suggest
that the p53-miR-125b-TEF axis has a significant influence on
cytoskeletal organization and cell shape.
Figure 2. Activation of p53 downmodulates TEF. (A) Nuclear
extracts from NB4 cells cultured at the indicated temperatures and
NTERA2 cells transfected with control or p53 shRNAs, were obtained
and analyzed for the formation of protein-DNA binding complexes by
EMSA. (B) The expression of TEF was analyzed in protein lysates from
NB4 cells following activation of p53 by western blot. The levels of a-
Tubulin were determined to assure equal loading. (C) HEK293T cells
were co-transfected with a TEF promoter-luciferase reporter vector and
with p53 cDNA or empty vector (pcDNA3). The mdm2 promoter was
included as a positive control of response to p53. After 24 h of
transfection, cell extracts were prepared and analyzed for the relative
luciferase activity. Results were normalized for transfection efficiency
with values obtained with pRSV-b-gal. All data points represent the
means 6 SD of three independent experiments.
doi:10.1371/journal.pone.0017169.g002
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In vivo models have demonstrated that mice deficient in TEF,
DBP and HLF, are hypersensitive to genotoxic drugs such as
cyclophosphamide and mitoxantrone, which induce p53-depen-
dent apoptosis [5]. We have shown that p53 downmodulates the
expression of TEF not by a direct transcriptional mechanism but
through a microRNA, miR-125b. The p53-mediated regulation of
miR-125b is consistent with recent data showing that miR-125
served as a tumor suppressor microRNA in tumor cells [22] and
that miR-125 is upregulated along with the p53 targets miR-34a-c,
in K562 cells in response to cisplatin [23], a p53-dependent
apoptotic inducer [24]. In addition, it has been shown that miR-
125b is a negative regulator of p53 [25], which would suggest a
negative feedback loop involved in the control of this tumor
suppressor. However, the same authors described that miR-125b
is downregulated in zebrafish embryos following p53 activation by
DNA-damaging agents. Furthermore, in other systems such as
leukemia cells, p53 protein levels were not altered by miR-125b
[26]. All these data reveal the complexity of this regulatory
network which may be influenced by the cellular context and the
activating signals received by the cells. The relevance of
microRNAs in mediating the activities of p53 is gaining support
by a number of recent publications. One of the most elegant works
provided evidence that miR-192, miR-194 and miR-215 can be
transcriptionally activated by p53 [15]. These microRNAs in turn
downmodulate MDM2, a negative regulator of p53, enhancing
the activity of this tumor suppressor gene, which may be a relevant
mechanism to control the genotoxic effects of stress stimuli in
different cell systems.
We have also demonstrated that TEF regulates the distribution
of actin filaments and the shape of fibroblasts. In line with the
TEF-mediated pathway described here, both p53 and miRs have
been involved in cell shape and cytoskeleton remodeling [8,27,28].
Recent data show that JMY, a transcriptional co-factor that
regulates the p53 response, represents a new class of multifunc-
tional actin assembly factor [29], and that LIMK2, a p53-target
gene upregulated by DNA damage, regulates actin dynamics [30].
Taken together, all these data suggest that a number of factors,
acting downstream of p53, ensure proper execution of checkpoint
arrest by modulating the dynamics of actin polymerization.
Interestingly, we observed that the absence of TEF in mouse
fibroblasts was accompanied by increase of cell area, decrease of
elongation (bipolarity) and dispersion (multipolarity), and appear-
ance of circumferential actin bundles. Cellular activities, including
cell shape, internalization of membrane vesicles, migration and
cell division depend on the control of actin dynamics by numerous
proteins, mainly Rho GTPases [31]. We showed no significant
differences in the mRNA levels of RhoA, Rac1 and Cdc42
between wild type and TEF (2/2) fibroblasts. However, although
Figure 3. miR-125b is induced in response to p53 activation. (A) The interaction between miR-125b and the 39UTR of TEF is shown as
predicted by PICTAR. (B) Total RNA was extracted from NB4 cells cultured at 37uCo r3 2 uC and analyzed for the expression of miR-125b by quantitative
RT-PCR. A known target of p53, miR34a, and the p53-unrelated miR-147, were also included as controls. Nuclear RNA RNU6B was used as a
normalization control. (C) NB4 cells were transfected with a p53 cDNA-containing vector and after 24 h, the expression of miR-125b was analyzed as
above. (D) NB4 cells were transfected with a luciferase reporter vector containing the miR-125b binding sequence downstream of the luciferase gene.
The same vector containing a mismatch sequence was also used as a negative control. After 16 h of transfection, cells were incubated at 32uC for
another 16 h period and then extracts were prepared and analyzed for the relative luciferase activity. Results were normalized for transfection
efficiency with values obtained with pRSV-b-gal. (E) HEK293T cells were co-transfected with the same luciferase reporters used in (D) and with miR-
125b or control miR-147. After 24 h of transfection, cell extracts were analyzed for the relative luciferase activity. Asterisks represent significant
differences (p,0.01) with the corresponding controls. Histograms show the means 6 SD of three independent experiments.
doi:10.1371/journal.pone.0017169.g003
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family contains more than twenty members, some of which seem
to have unique roles in the regulation of actin dynamics [32].
Therefore, further studies need to be done to elucidate if any Rho
GTPase is a target of TEF or alternatively whether key proteins of
signal transduction cascades from membrane receptors to Rho
proteins or from Rho proteins to microtubules are transcription-
ally regulated by TEF.
Consistent with our previous findings, genetic manipulation of the
p53-miR-125b-TEF axis directed the cells toward the expected
morphological profile characteristic of either wild type or TEF (2/2),
phenotypes. To this end, expression of some p53 mutants and to
a lesser extent wild type p53, lead to increase of average cell area,
decrease of dispersion and elongation indices, and re-appearance
of actin bundles [8]. p53 expression is elevated in damaged
neurons in acute models of injury such as ischemia and epilepsy
and in brain tissue samples derived from patients with chronic
neurodegenerative diseases, which is consistent with data showing
that the absence of p53 protects neurons from a wide variety of
acute toxic insults [33]. This is in good agreement with the
epileptic phenotype and the hypersensitivity to cytotoxic agents of
mice lacking TEF family members and the data presented here
showing that TEF is downregulated by p53. Therefore, if p53 has
been implicated in seizure neuronal damage, downregulation of
TEF through a p53-mediated induction of miR-125b, could
contribute to the overall apoptotic response promoted by
activation of this suppressor gene. Although we must take into
consideration that our data were mostly obtained using mouse
fibroblasts, we may hypothesize that the miR-125b-dependent
regulation of TEF contributes to the response to p53 activation in
both physiological conditions (i.e., response to cellular stress
stimuli) and certain degenerative diseases. The biological
importance of miRs, initially demonstrated in cancer, has been
extended to other diseases and the physiology of normal cells.
Although we do not know the molecular link between actin
filaments and TEF, we might speculate that genetic alterations of this
transcription factor could disrupt the normal cytoskeletal dynamics of
neurons in a way similar to that observed in TEF (2/2)
fibroblasts. Future studies will need to be done in order to establish
an association between TEF or other PAR bZIP gene mutations and
epilepsy or other neuronal disorders. Overall, we set the basis of a
regulatory pathway orchestrated by p53 which modifies the
expression levels of TEF through activation of miR-125b, and
showed that this pathway has a significant influence on cytoskeletal
organization and cell shape.
Materials and Methods
Cell cultures
Fibroblasts were obtained from tail tips (kindly provided by Dr.
Ueli Schibler) of wild type and TEF knockout mice [4]. Mouse
tails were minced and digested with 1 mg/ml type 1 collagenase in
Dulbecco’s modified Eagle’s medium (DMEM) (Invitrogen,
Carlsbad, CA) containing 100 units/ml penicillin and 100 mg/
ml streptomycin for 1 hr at 37uC. After letting the tissue fragments
settle, the supernatant was collected and one-tenth volume of fetal
calf serum (FCS) (Flow Laboratories, Irvine, CA) was added to
stop the collagenase action. The remaining tissue fragments were
redigested for an additional 1 h and the resulting cell suspension
was centrifuged and resuspended in DMEM with 10% FCS and
antibiotics. Thus, each culture was derived from one tail, without
any clonal selection. In all experiments, both wild type and TEF
(2/2) cells were used between passages 3 and 6.
Human embryonal carcinoma cell line NTERA-2 and
HEK293T cells (both from ATCC, Manassas, VA), were
maintained in DMEM supplemented with 10% FCS. NB4-tsp53
leukemia cell line [34], a NB4 derivative transfected with a
temperature-sensitive mutant form of p53, was grown in RPMI
1640 with 10% FCS.
To determine mitochondrial membrane potential, cells were
incubated with 20 nM 3,39-dihexyloxacarbocyanine iodide and
propidium iodide for 30 min at 37uC and analyzed immediately
by flow cytometry.
Electrophoretic Mobility Shift Assay (EMSA)
Cells were lysed and nuclear fractions were resuspended in
20 mM HEPES pH 7.9, 420 mM NaCl, 1 mM EDTA, 1 mM
EGTA, and 20% glycerol. Nuclear extracts (5–10 mg of total
protein) were incubated with a
32p-labeled double stranded DNA
target of TEF [6]. Samples were run on a 5% non-denaturing
polyacrylamide gel in 200 mM Tris-borate, 2 mM EDTA. Gels
were dried and visualised by autoradiography.
Analyses of microRNAs
MicroRNAs miR-34a, miR-147 and miR-125b were quantified
by qPCR (TaqMan MicroRNA Assay, Applied Biosystems, Foster
City, CA), according to the instructions supplied by the
manufacturer. The small nuclear RNA RNU6B, was used as
internal control and for normalization. Amplifications were
Figure 4. miR-125b downregulates TEF. (A) Wild type mouse
fibroblasts were transfected with a FAM-labeled, random sequence
control miR and the transfection efficiency was determined as the
percentage of fluorescent cells by flow cytometry. C, unlabeled
negative control miR. (B) Following 4 days of transfection with miR-
125b or control miR, the protein levels of TEF were determined by
western blot. The expression of a-Tubulin was determined to assure
equal loading. (C) Nuclear extracts from wild type fibroblasts
transfected with miR-34a, miR-125b or miR-147, were analyzed for the
formation of TEF-DNA binding complexes by EMSA. Cells overexpress-
ing TEF were also included to verify the specificity of the complex.
doi:10.1371/journal.pone.0017169.g004
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Biosystems).
Cell Cycle Analyses
For DNA cell cycle analysis, cells were fixed in 70% ethanol,
washed in PBS and treated with 100 mg/ml ribonuclease. Then,
cells were labeled with 100 mg/ml propidium iodide for 15 min
and analyzed by flow cytometry (FACSCalibur, BD Biosciences)
using the ModFit software.
Analyses of mRNA expression
Total RNA was extracted using the RNeasy mini kit (Qiagen,
Valencia,CA).To assessthe expression ofindividualgenes,a cDNA
was generated and amplified by using primers for mouse Cdc42
(
59GCCTATTACTCCAGAGACTGC
39), and (
59GTTCATAG-
CAGCACACACCTG
39), RhoA (
59GTTGGTGATGGAGCTT-
GTGG
39), and (
59GCAGGCGGTCATAATCTTCC
39), Rac1
(
59AGGCCATCAAGTGTGTGGTG
39), and (
59CTTGTCCAG-
CTGTGTCCCAT
39), and b2-microglobulin (
59GGCCTGTA-
TGCTATCCAGAAA
39)a n d(
59GGCGTATGTATCAGTCT-
CAGTGG
39). Quantitative real-time PCR was performed in a
7000 Sequence Detection System (Applied-Biosystems, Foster City,
CA). The ratio of the abundance of the different transcripts to that
of b2-microglobulin transcripts was calculated as 2
n, where n is the
CT (threshold cycle) value of b2-microglobulin minus the CT value
of the target mRNA. Specificity of the desired PCR products was
determined with melting curve analysis.
Western blot analysis
P r o t e i ne x p r e s s i o nw a sd e t e r m i n e db yw e s t e r nb l o t t i n ga s
previously described [35]. Proteins (30 to 60 mg) were separated
on a 12% polyacrylamide gel, and transferred to nitrocellulose.
Blots were blockedwith 3% bovine serum albumin andincubated
with rabbit antibodies against p53, p21 (Santa Cruz Biotechnol-
ogy, Santa Cruz, CA), and TEF (Aviva Systems Biology, San
Diego, CA) or mouse anti-a-Tubulin antibodies (SIGMA, St
Louis, MO), and then incubated with goat anti-rabbit or anti-
mouse antibodies conjugated to alkaline phosphatase (SIGMA).
Bound antibody was detected by a chemiluminescence system
(Applied Biosystems).
Figure 5. Morphological differences between wild type and TEF (2/2) fibroblasts. (A) The morphology of wild type (WT) and TEF (2/2)
fibroblasts in culture was assessed by phase contrast microscopy. Scale bar: 40 mm. (B) Both cell populations were labeled red with phalloidin for
staining the actin filaments and visualized by confocal microscopy. Scale bars: 20 mm. (C) Confluent cultures were mechanically disrupted, leaving an
area devoid of cells, and fibroblasts were labeled green to determine the actin distribution at the leading edge. Scale bar: 20 mm. (D) The mRNA
expression of different Rho GTPases was analyzed by quantitative RT-PCR. The expression levels in TEF (2/2) cells were referred to those in wild type
cells. Histograms represent the mean 6 SD of three independent experiments. (E) Distribution of cell cycle phases in wild type and TEF (2/2)
fibroblasts was determined by flow cytometry after staining nuclei with propidium iodide. The percentage of cells in the different phases, G0/G1, S,
and G2/M, is indicated.
doi:10.1371/journal.pone.0017169.g005
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NTERA2 cells were stably transfected with a p53 shRNA
plasmid (Mission shRNA, SIGMA) by using Lipofectamine 2000
and selected with puromycin. Transfection of NB4 cells was
performed using the cell line nucleofector kit V (Lonza, Basel,
Switzerland). Wild type fibroblasts were transfected with miR-34a
or miR-125b precursors (Applied Biosystems) using Hyperfect. A
FAM-labeled, random sequence pre-miR was used for monitoring
transfection efficiency by flow cytometry.
A genomic PCR fragment of 2 kb from the promoter region of
mouse TEF, was cloned into KpnI and HindIII sites of the pGL2-
basic luciferase reporter vector (Promega Corp., Madison, WI). The
authenticity of the construct was confirmed by sequencing.
HEK293T cells were co-transfected with 1 mg of the promoter-
containing pGL2 construct, 1 mg of p53 cDNA cloned in the
pcDNA3 expression vector, and 20 ng of pRSV-b-gal by using
Superfect. 24 h post-transfection, cell extracts were prepared and
analyzed for the relative luciferase activity by a dual-light reporter
gene assaysystem(Applied Biosystems).Resultswere normalized for
transfection efficiency with values obtained with pRSV-b-gal.
Double-stranded oligonucleotides corresponding to the 39 untrans-
lated region of mouse TEF, which contain the miR-125b binding
sequence (
59GAGGGTGTGTTTGTTTGCTCAGGGCGGGCA-
GCCT
39) or a mismatch sequence (
59GAGGGTGTGTTTGTCC-
GAAGCATACGGTGTGCCT
39) was cloned into XhoI and SmaI
sites of the psiCHECK-1 reporter vector (Promega). HEK293T cells
were transfected with these constructs (1 mg), as indicated above.
pRSV-b-gal was also used to normalize transfections.
When indicated, wild type fibroblast were cotransfected with
1 mg of pCMV-DsRed (Clontech, Mountain View, CA), and 1 mg
of either TEF cDNA [6] or an empty pCMV vector. After 24 h of
transfection, DsRed-positive cells were sorted by flow cytometry
and subsequently cotransfected with 375 ng of miR-125b and
FAM-labeled miR. Transfected cells were visualized 48 h later
under a fluorescence microscope.
Immunofluorescence
Cells were assayed for the intracellular distribution of actin
filaments (F-actin). Briefly, mouse fibroblasts were grown on
10610 mm coverslips and then fixed in 3.7% formaldehyde and
permeabilized with 0.5% Triton X-100. For staining actin
filaments, cells were incubated with Tetramethylrhodamine iso-
thiocyanate (TRITC)-labeled or FITC-labeled Phalloidin (SIGMA)
for 20 min at room temperature. When indicated, TEF (2/2)
fibroblasts were transfected with TEF cDNA, and wild type cells
were transfected with miR-125b. After 48 h of transfection,
fibroblasts were subjected to immunofluorescence analysis. All cell
samples were mounted with VectaShield (Vector Laboratories,
Burlingame, CA) and examined with a LSM-510 laser scanning
microscope (Carl Zeiss Inc, Germany), equipped with an argon
(488 nm) and HeNe (543 nm) ion lasers and using 406and 636oil
(1.4 NA) objectives. Each channel was recorded independently, and
pseudocolor images were generated and superimposed.
Statistical analysis
All statistics were calculated with the SPSS statistical package
(version 13.0). Categoric variables were compared using the Chi-
square test. The Student t test was used to compare continuous
variables, summarized as means6SD, between two groups. The
significance level was set at p,0.05.
Figure 6. Overexpression of TEF, miR-125b or p53 modifies the cell phenotype. (A) TEF (2/2) fibroblasts were cotransfected with empty
vector (pcDNA3) or TEF and an EGFP-containing vector. After 48 h of transfection, cells were labeled red with phalloidin and visualized by confocal
microscopy. (B) Wild type cells were cotransfected with control miR or miR-125b and a FAM-labeled miR. Actin filaments were stained with phalloidin
48 h after transfection. Green and red fluoresce images were collected from different focal planes. (C) Wild type fibroblasts were cotransfected witha
TEF cDNA lacking the miR-125b binding sequence (TEF –125b site) and miR-125b and then, the number of cells having a TEF(2/2)-like morphology
was quantitated. Unmodified TEF was also included for comparison. Asterisks represent significant differences (p,0.01) with the corresponding
control (empty vector transfected cells). (D) Wild type fibroblasts were cotransfected with pcDNA3 or p53 and an EGFP-containing vector and
analyzed as described above. Scale bars: 10 mm. Quantifications were performed in triplicate, counting a minimum of 100 total cells each. C, control
transfected cells. Histograms represent the mean 6 SD.
doi:10.1371/journal.pone.0017169.g006
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